In Quebec, anti-obesity medications are on the list of exclusions of the Régie de l’assurance maladie du Québec (RAMQ). Quebec is the only Canadian province that does not evaluate obesity medications ...

Semaglutide outperformed 7 diabetes medications in reducing risk of Alzheimer's disease, according to a study of over 1 ...

Ozempic and other GLP-1 drugs show promise not only in managing obesity and diabetes but also in reducing Alzheimer's risk. A ...

Here's what to know about weight loss drugs such as Wegovy and Zepbound. CR helps you decide whether semaglutide or ...

GLP-1 drugs like Wegovy (NVO) might help with weight loss, but they aren’t leading to lower health care costs yet, according ...

As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...

The U.K. government issued a new warning aimed at the misuse of GLP-1 therapies by those who don’t qualify for the meds but are instead using them for quick-fix weight loss.

Karan Johar's noticeable weight loss has sparked rumours about his possible use of Ozempic, a diabetes drug known for its ...

Some fibers, like oat beta-glucans and wheat dextrin, are water- soluble, meaning they are easily fermented by gut bacteria.

Renowned plant-based physician Dr. Michael Greger has released a new book on the risks, benefits, and alternatives to Ozempic ...

Nationally, employers could see total health insurance costs rise 5.8% on average in 2025. KC won't be spared costlier ...